Q&A on COVID-19 reinfection

December 30, 2022

While many people are recovering from the novel coronavirus infection, some people worry if they could get reinfected quickly. Let's check the facts on reinfection.
Learn more about the world of Chinese tea

December 30, 2022

The project "Traditional tea processing techniques and associated social practices in China" was included in List of Representative Works of Human Intangible Cultural Heritage on Nov 29.
Village preserves traditional hand-made brown sugar techniques

December 30, 2022

Zhoucun village, Zhuji, a county-level city under the administration of Shaoxing in East China's Zhejiang province, is one of the few places in China that still cherishes traditional Chinese brown sugar-making techniques.
Nearly 100,000 people in Shaoxing receive second booster shots

December 29, 2022

About 99,000 residents in Shaoxing, East China's Zhejiang province, have been administered a second booster shot of a COVID-19 vaccine as the national vaccination campaign speeds up, according to an announcement made at a news conference on Shaoxing's work in epidemic control on Dec 24.
Nation takes big leap on vaccinations

December 29, 2022

Targeted inoculation programs, medical innovations drive fight against COVID-19
Changes to COVID management policies explained

December 28, 2022

The National Health Commission announced late Monday that it will reclassify the novel coronavirus, changing it from "novel coronavirus pneumonia" to "novel coronavirus infection" and simultaneously downgrading management of the disease from Class A to Class B in accordance with the national law on infectious disease prevention and treatment, as of Jan 8.
Investment projects signed in Shengzhou

December 28, 2022

The projects are centered on new energy, biological medicine and new materials.
China to manage COVID-19 with measures against Class B infectious diseases

December 27, 2022

China will manage COVID-19 with measures against Class B infectious diseases, instead of Class A infectious diseases, in a major shift of its epidemic response policies.